Mass spectrometry-based identification of a naturally presented receptor tyrosine kinase-like orphan receptor 1-derived epitope recognized by CD8+ cytotoxic T cells

• Falk Heidenreich,
• Elke Rücker-Braun,
• Juliane S. Walz,
• Anne Eugster,
• Denise Kühn,
• Sevina Dietz,
• Annika Nelde,
• Antje Tunger,
• Rebekka Wehner,
• Cornelia S. Link,
• Jan M. Middeke,
• Friedrich Stölzel,
• Torsten Tonn,
• Stefan Stevanovic,
• Hans-Georg Rammensee,
• Ezio Bonifacio,
• Michael Bachmann,
• Matthias Zeis,
• Gerhard Ehninger,
• Martin Bornhäuser,
• Johannes Schetelig,
• Marc Schmitz

Affiliations

Falk Heidenreich

DKMS German Bone Marrow Donor Center, Clinical Trials Unit, Dresden, Germany;Department of Medicine I, University Hospital of Dresden, Germany

Elke Rücker-Braun

Department of Medicine I, University Hospital of Dresden, Germany;Center for Regenerative Therapies Dresden, TU Dresden, Germany

Juliane S. Walz

Department of Hematology and Oncology, University of Tübingen, Germany

Anne Eugster

Center for Regenerative Therapies Dresden, TU Dresden, Germany

Denise Kühn

Center for Regenerative Therapies Dresden, TU Dresden, Germany

Sevina Dietz

Center for Regenerative Therapies Dresden, TU Dresden, Germany

Annika Nelde

Department of Hematology and Oncology, University of Tübingen, Germany;Department of Immunology, Institute for Cell Biology, University of Tübingen, Germany

Antje Tunger

Institute of Immunology, Medical Faculty Carl Gustav Carus, TU Dresden, Germany;National Center for Tumor Diseases, University Hospital Carl Gustav Carus, TU Dresden, Germany

Rebekka Wehner

Institute of Immunology, Medical Faculty Carl Gustav Carus, TU Dresden, Germany;National Center for Tumor Diseases, University Hospital Carl Gustav Carus, TU Dresden, Germany

Cornelia S. Link

Department of Medicine I, University Hospital of Dresden, Germany;Center for Regenerative Therapies Dresden, TU Dresden, Germany

Jan M. Middeke

Department of Medicine I, University Hospital of Dresden, Germany

Friedrich Stölzel

Department of Medicine I, University Hospital of Dresden, Germany

Torsten Tonn

German Red Cross Blood Donation Service North-East, Dresden, Germany

Stefan Stevanovic

Department of Immunology, Institute for Cell Biology, University of Tübingen, Germany;German Cancer Consortium (DKTK), Tübingen, Germany;German Cancer Research Center (DKFZ), Heidelberg, Germany

Hans-Georg Rammensee

Department of Immunology, Institute for Cell Biology, University of Tübingen, Germany;German Cancer Consortium (DKTK), Tübingen, Germany;German Cancer Research Center (DKFZ), Heidelberg, Germany

Ezio Bonifacio

Center for Regenerative Therapies Dresden, TU Dresden, Germany

Michael Bachmann

Center for Regenerative Therapies Dresden, TU Dresden, Germany;National Center for Tumor Diseases, University Hospital Carl Gustav Carus, TU Dresden, Germany;German Cancer Research Center (DKFZ), Heidelberg, Germany;German Cancer Consortium (DKTK), Dresden, Germany;Department of Radioimmunology, Institute of Radiopharmaceutical Cancer Research, Helmholtz Center Dresden-Rossendorf, Dresden, Germany

Matthias Zeis

Städtisches Krankenhaus Kiel, Germany

Gerhard Ehninger

Department of Medicine I, University Hospital of Dresden, Germany;Center for Regenerative Therapies Dresden, TU Dresden, Germany;National Center for Tumor Diseases, University Hospital Carl Gustav Carus, TU Dresden, Germany;German Cancer Research Center (DKFZ), Heidelberg, Germany;German Cancer Consortium (DKTK), Dresden, Germany

Martin Bornhäuser

Department of Medicine I, University Hospital of Dresden, Germany;Center for Regenerative Therapies Dresden, TU Dresden, Germany;National Center for Tumor Diseases, University Hospital Carl Gustav Carus, TU Dresden, Germany;German Cancer Research Center (DKFZ), Heidelberg, Germany;German Cancer Consortium (DKTK), Dresden, Germany

Johannes Schetelig

DKMS German Bone Marrow Donor Center, Clinical Trials Unit, Dresden, Germany;Department of Medicine I, University Hospital of Dresden, Germany

Marc Schmitz

Center for Regenerative Therapies Dresden, TU Dresden, Germany;Institute of Immunology, Medical Faculty Carl Gustav Carus, TU Dresden, Germany;National Center for Tumor Diseases, University Hospital Carl Gustav Carus, TU Dresden, Germany;German Cancer Research Center (DKFZ), Heidelberg, Germany;German Cancer Consortium (DKTK), Dresden, Germany